RT Boost Breast — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — A boost (10-16 Gy) to the tumour bed after WBRT is recommended for women at higher risk of local recurrence — age ≤50, high grade, close margins, LVSI; the EORTC boost trial showed a 50% relative reduction in local recurrence
The EORTC 22881-10882 boost trial demonstrated that a 16 Gy boost to the tumour bed after WBRT reduced local recurrence by approximately 50% relative risk. The absolute benefit is greatest in women ≤50 years (highest baseline recurrence risk). NICE NG101 recommends discussing a boost for: age ≤50, high grade (3), close margins, LVSI. For older women with low-risk tumours, the absolute benefit is small and the boost may be omitted. Boost techniques include electron beam, photon mini-tangents and brachytherapy.
Reference: NICE NG101; EORTC boost trial Bartelink et al Lancet Oncol 2015; ESMO 2024